Guotai CSI Medical Service ETF (159828) Gains 1.13% in Morning Trading; Institutions State AI Has Become the Core Productivity Force of Medical New Infrastructure

NewTimeSpace News - As of 11:06 on January 29, 2026, the Medical ETF (159828) gained 1.13%, with its latest price reaching 0.45 yuan. Looking at a longer timeframe, as of January 28, 2026, the ETF posted a cumulative gain of 2.78% over the past month, ranking 2nd out of 4 comparable funds. (Stocks listed above are constituent stocks of the index and do not constitute specific investment recommendations.)

In terms of liquidity, the Medical ETF recorded an intraday turnover rate of 2.53%, with trading volume reaching 56.3885 million yuan. Looking at a longer timeframe, as of January 28, the average daily trading volume over the past month stood at 105 million yuan.

On the size front, the Medical ETF's assets under management grew by 51.8214 million yuan over the past week, achieving significant growth and ranking 2nd out of 4 comparable funds. (Data source: Wind)

Regarding shares outstanding, the Medical ETF's latest share count reached 4.996 billion units, marking a new high for the past six months and ranking 2nd out of 4 comparable funds. (Data source: Wind)

From a capital flow perspective, the Medical ETF has seen continuous net capital inflows for the past 9 days, with the highest single-day net inflow reaching 43.5128 million yuan, accumulating to a total of 217 million yuan in attracted funds and an average daily net inflow of 24.1496 million yuan. (Data source: Wind)

Data shows that leveraged funds continue to build positions. The Medical ETF recorded net purchases from leveraged funds for three consecutive days, with the highest single-day net purchase reaching 6.2665 million yuan, while the latest margin financing balance stood at 77.9877 million yuan. (Data source: Wind)

As of January 28, the ETF's NAV has gained 15.27% over the past year. In terms of return capability, as of January 28, 2026, since the ETF's inception, its highest monthly return reached 30.02%, with the longest consecutive winning streak lasting 5 months and generating a cumulative gain of 23.83%. The average monthly return during up months stands at 5.85%. As of January 28, 2026, the ETF's annualized excess return over its benchmark over the past three months reached 1.60%, ranking in the top 2/4 of comparable funds.

As of January 23, 2026, the Medical ETF's Sharpe ratio over the past year stood at 1.18.

Regarding drawdowns, as of January 28, 2026, the ETF's maximum year-to-date drawdown was 8.79%, with a relative drawdown against its benchmark of 0.06%.

On fees, the Medical ETF's management fee rate is 0.50% and custodian fee rate is 0.10%.

In terms of tracking accuracy, as of January 28, 2026, the ETF's tracking error over the past month stood at 0.017%, indicating relatively high tracking precision among comparable funds.

The Medical ETF closely tracks the CSI Healthcare Index, which selects listed securities in the healthcare sector covering medical devices, medical services, medical informatization and other healthcare themes as index constituents, aiming to reflect the overall performance of healthcare-themed listed securities.

Everbright Securities stated that domestic and international medical companies continue to deploy AI products and services, covering multiple industrial chain segments including health management, AI precision medicine, AI digital clinical trials, AI drug discovery, AI sequencing, and AI medical imaging. The firm is optimistic about the industry cycle of AI healthcare transitioning from technical validation to commercial fulfillment, as AI has become the core productivity force of medical new infrastructure.

NewTimeSpace Disclaimer: All content herein is the original work of NewTimeSpace. Any reproduction, reprinting, or use of this content in any other manner must clearly indicate the source as "NewTimeSpace". NewTimeSpace and its authorized third-party information providers strive to ensure the accuracy and reliability of the data, but do not guarantee the absolute correctness thereof. This content is for reference only and does not constitute any investment advice. All transaction risks shall be borne by the user.